首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

ANNALS OF THE RHEUMATIC DISEASES
ISSN：0003-4967

ANNALS OF THE RHEUMATIC DISEASES

ANN RHEUM DIS
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：平均1.4月
新锐分区：医学1区
年发文量：153
影响因子：20.6
JCR分区：Q1
期刊官网： http://ard.bmj.com/

基本信息

Annals of the Rheumatic Diseases (ARD) 是一份国际同行评审期刊，致力于促进科学交流和教育的最高标准。它涵盖了风湿病学的所有方面，包括肌肉骨骼疾病、关节炎和结缔组织疾病的范围。 ARD 发表基础、临床和转化科学研究。鼓励简明的科学交流，并介绍国际会议的同行评审记录。教育论文包括最先进的评论、“如何”文章和关注临床实践中面临的问题的教育案例。该杂志于 1939 年首次出版，拥有权威的全球编辑委员会和不断增长的国际读者群。
0003-4967SCIE/Scopus收录
20.6
点击查看最新影响趋势>
21.6
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
RHEUMATOLOGY 风湿病学
1区
是
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：RHEUMATOLOGY
SCIE
Q1
2/58
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：RHEUMATOLOGY
SCIE
Q1
2/58
212
153
点击查看年发文量趋势图>
3%约25%平均1.4月-医学-风湿病学
3.4%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
90.85%38.34%-
CiteScore：33.20
SJR：5.731
SNIP：4.435
学科类别分区排名百分位
大类：Medicine
小类：Rheumatology
Q1
1 / 76
大类：Medicine
小类：General Biochemistry, Genetics and Molecular Biology
Q1
4 / 225
大类：Medicine
小类：Immunology
Q1
6 / 240
大类：Medicine
小类：Immunology and Allergy
Q1
6 / 231

期刊高被引文献

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2018-213336
AB0518\u2005- JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS RELATED PANCREATITIS: AN UNCOMMON MANIFESTATION OF A COMMON DISEASE
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.7507
Remission or low disease activity as a target in systemic lupus erythematosus
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2017-212876
AB0183\u2005THE ROLE OF THE PHOSPHOLIPASE LP-PLA2 ACTIVITY IN SJOGREN’S SYNDROME RELATED LYMPHOMAGENESIS: A NEW SERUM BIOMARKER?
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.5758
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’ by Vandergheynst et al
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-215658
Wrist ultrasound - the model method for grey-scale and power Doppler scoring
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2018-213977
FRI0175\u2005PREDICTORS OF LOW DISEASE ACTIVITY AND CLINICAL REMISSION FOLLOWING BELIMUMAB TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.6376
SAT0306\u2005COMPARISON OF MEN AND WOMEN WITH AXIAL SPONDYLOARTHRITIS IN THE US-BASED CORRONA PSORIATIC ARTHRITIS/SPONDYLOARTHRITIS (PSA/SPA) REGISTRY
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.1154
SAT0347\u2005COMORBID CONDITIONS ARE ASSOCIATED WITH HIGHER DISEASE ACTIVITY AND WORSE FUNCTIONAL STATUS IN AXIAL SPONDYLOARTHRITIS: A POPULATION-BASED ANALYSIS OF INSURANCE CLAIMS LINKED TO PATIENT SURVEY DATA
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.4602
Response to: “How to communicate in science” by Klareskog et al
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-216045
THU0399\u2005DEVELOPMENT OF AN OPTIMIZED ONLINE SELF-REFERRAL TOOL FOR EARLY RECOGNITION OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS (AXSPA) – DATA FROM THE ’OPTIREF’-STUDY
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.4688
FRI0418\u2005SECUKINUMAB PROVIDED SIMILAR EFFICACY IN MALES AND FEMALES WITH ACTIVE ANKYLOSING SPONDYLITIS OVER 52 WEEKS: POST HOC POOLED ANALYSIS OF THE MEASURE TRIALS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.1834
FRI0594\u2005COMPARISON OF CLINICAL FEATURES BETWEEN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS COMPLICATED WITH RHEUMATIC DISEASES OR TUMOR
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.2772
SAT0124\u2005MOLECULAR CHARACTERIZATION OF THE SERUM PROFILE ASSOCIATED TO THE INCREASED CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS. EFFECTS OF BIOLOGICAL DRUGS.
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.7338
SAT0485\u2005THE FIRST 18 MONTHS OF A PEDIATRIC RHEUMATOLOGY SERVICE AT A TERTIARY REFERRAL HOSPITAL IN KENYA
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.1169
AB1041\u2005PREVALENCE OF JUVENILE IDIOPATHIC ARTHRITIS (JIA) SUBGROUPS AND JIA-ASSOCIATED UVEITIS AMONG JIA PATIENTS ADMITTED TO REFERRAL PEDIATRIC RHEUMATOLOGY CLINICS IN TURKEY: A RETROSPECTIVE STUDY, JUPITER
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.3138
AB0245\u2005PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE)
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.2890
AB0390\u2005CORRELATION BETWEEN TNF-BLOCKERS BIOAVAILABILITY AND FCGRIIA H131R POLYMORPHISM IN TUNISIAN PATIENTS WITH RHEUMATOID ARTHRITIS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.8031
SAT0309\u2005CLINICAL, IMAGING AND BIOLOGIC FEATURES OF SPONDYLOARTHRITIS IN AN AT-RISK POPULATION: DATA FROM THE PRE-SPA COHORT
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.5323
THU0636\u2005HIGHER SOCIAL MEDIA USER STICKINESS ON SELF-MANAGEMENT SYSTEM MAY IMPROVE THE REMISSION RATE OF PATIENTS WITH ANKYLOSING SPONDYLITIS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.3938
FRI0337\u2005INCIDENCE AND PREVALENCE OF MYOSITIS ASSESSED BY MULTI-SOURCES CAPTURE-RECAPTURE METHODOLOGY
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.5556
SAT0381\u2005MINIMAL DISEASE ACTIVITY IN PSORIATIC ARTHRITIS PREDICTS LOW IMPACT OF DISEASE
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.7172
FRI0256\u2005ASSESSING THE PREVALENCE AND USE OF VALIDATED SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY METRICS IN REAL WORLD PRACTICE
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.4239
AB0054\u2005SEQUENTIAL INTRA-ARTICULAR INJECTIONS OF LINEAR AND CROSS-LINKED HYALURONIC ACIDS IN THE TREATMENT OF GONARTHROSIS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.7357
FRI0265\u2005ANTI-IGE AND ANTI-IL5 THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.5116
FRI0151\u2005THE RELATIONSHIP BETWEEN THE EFFECTIVENESS OF METHOTREXATE (MTX) IN RHEUMATOID ARTHRITIS (RA) AND MTX POLYGLUTAMATES LEVELS (MTXPGS) IN RED BLOOD CELLS BY TANDEM CHROMATOMASS SPECTROMETRY (PILOT STUDY)
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.1260
FRI0210\u2005EVALUATION OF THE IMPACT OF ROUTINE MONITORING OF BLOOD HYDROXYCHLOROQUINE LEVELS ON ADHERENCE TO TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.6927
OP0284\u2005PARE THE INFLUENCE OF FUNCTIONAL TRAINING AND PSYCHO-SOCIAL SUPPORT
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.4256
FRI0062\u2005INFECTIONS AMONG RHEUMATOID ARTHRITIS PATIENTS STARTING OR SWITCHING BIOLOGICAL AGENTS. A SYSTEMATIC LITERATURE REVIEW
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.3175
FRI0121\u2005IMPROVEMENT OF MATRIX METALLOPROTEINASE-3 AT 12 WEEKS IS AN INDEPENDENT PREDICTIVE FACTOR FOR ACHIEVEMENT OF LOW DISEASE ACTIVITY AT 52 WEEKS IN BIO-SWITCH RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.2338
AB0899\u2005COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.6627
Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Buch et al
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-215903
SAT0700-HPR\u2005PHYSICAL AND PSYCHOLOGICAL DETERMINANTS OF FIBROMYALGIA SEVERITY: A STRUCTURAL EQUATION MODELLING FROM THE AL-ÁNDALUS CROSS-SECTIONAL STUDY
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.5805
P112\u2005Studying cellular senescence in human lymph node stromal cells during the earliest phases of rheumatoid arthritis
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2018-EWRR2019.100
FRI0226\u2005LOW EXPRESSION OF ESTROGEN RECEPTOR BETA IN RENAL TUBULAR EPITHELIAL CELL MAY CONTRIBUTE TO HYPERURICEMIA IN PREMENOPAUNITED STATES OF AMERICAL FEMALE SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.3586
AB0558\u2005TIME OF DIAGNOSTICS OF SJOGREN’S SYNDROME DEPENDING ON ITS FIRST MANIFESTATION
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.7732
AB1023\u2005PHYSICAL ACTIVITY LEVEL IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITISIN THE GERMAN NATIONAL PAEDIATRIC RHEUMATOLOGIC DATABASE: A COMPARISON WITH THE GENERAL POPULATION
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.6031
SAT0686\u2005ONLINE EDUCATION IMPROVES PHYSICIANS’ KNOWLEDGE OF FAMILY PLANNING AND PREGNANCY MANAGEMENT IN WOMEN WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.4173
P022/O02\u2005Distinct macrophage phenotype and bioenergetic profiles in rheumatoid arthritis
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2018-EWRR2019.16
THU0422\u2005COMPARISON OF PRP DERIVED GROWTH FACTOR (PRGF) VERSUS HYALURONIC ACID (HA) IN MILD TO MODERATE KNEE OSTEOARTHRITIS; A SINGLE BLIND ONE YEAR RANDOMIZED CLINICAL TRIAL STUDY
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.2294
SAT0638\u2005INCREASED LEVELS OF CIRCULATING EXTRA CELLULAR LONG NON-CODING RNAS MALAT1, MEG3 AND NEAT1 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND THEIR IMPACT ON DISEASE ACTIVITY MEASURES
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.6797
AB1378-HPR\u2005EFFECT OF CLINICAL CHARACTERISTICS, HABITS, PHYSICAL ACTIVITY LEVELS AND FUNCTIONAL CAPACITY ON QUALITY OF LIFE IN SYSTEMIC SCLEROSIS PATIENTS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.2659
FRI0353\u2005MISREGULATION OF BMP/TGFβ SHEDS LIGHT ON THE PATHOGENICITY OF HLA-B27 IN SPONDYLOARTHRITIS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.3344
SAT0717-HPR\u2005CONSTRUCT VALIDITY AND RELIABILITY OF A PORTUGUESE VERSION OF THE ANIMATED ACTIVITY QUESTIONNAIRE (AAQ)
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.3195
AB0388\u2005COMPARATIVE EFFECTIVENESS OF RITUXIMAB, TOCILIZUMAB AND TNFI BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS. INFLUENCE OF CLINICAL AND INFLAMMATORY PROFILES
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.7072
AB0820\u2005COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.4257
SAT0626\u2005THE INFLUENCE OF MEDITERRANEAN DIET IN RHEUMATOID ARTHRITIS: A MONOCENTER CROSS-SECTIONAL STUDY
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.3248
THU0441\u2005IMPROVED KNEE PHYSICAL FUNCTION CORRELATES SIGNIFICANTLY WITH TIBIOFEMORAL CARTILAGE THICKNESS INCREASE AFTER IA TPX-100: RESULTS OF A POST HOC ANALYSIS
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.1966
OP0253\u2005WORLDWIDE TRENDS IN MORTALITY OF SYSTEMIC LUPUS ERYTHEMATOSUS BETWEEN 2000 AND 2015: ANALYSIS OF THE WORLD HEALTH ORGANIZATION DATABASE
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/ANNRHEUMDIS-2019-EULAR.3721
AB1043\u2005CLINICAL OUTCOMES OF ANTI-NUCLEAR ANTIBODY POSITIVENESS IN THE 0-18 AGE GROUP: SINGLE-CENTER REAL-WORLD EXPERIENCE
来源期刊：Annals of the Rheumatic DiseasesDOI：10.1136/annrheumdis-2019-eular.7743

相关文章

ANNALS OF THE RHEUMATIC DISEASES中科院一区、IF20.6，JCRQ1，未被预警，自引率合理，年发文量524篇
2025-10-09
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15

期刊推荐

Acta Biomaterialia封面

Acta Biomaterialia

学科领域：医学
影响因子：9.6
中科院分区： 1区
ACTA PHARMACOLOGICA SINICA封面

ACTA PHARMACOLOGICA SINICA

学科领域：医学
影响因子：8.4
中科院分区： 1区
ADVANCED DRUG DELIVERY REVIEWS封面

ADVANCED DRUG DELIVERY REVIEWS

学科领域：医学
影响因子：17.6
中科院分区： 1区
AGEING RESEARCH REVIEWS封面

AGEING RESEARCH REVIEWS

学科领域：医学
影响因子：12.4
中科院分区： 1区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学1区
RHEUMATOLOGY 风湿病学
1区
是
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学1区
RHEUMATOLOGY 风湿病学
1区
是
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
RHEUMATOLOGY 风湿病学
1区
是
否